EFFECT OF METHYL TESTOSTERONE ON URINARY 17-KETOSTEROIDS OF ADRENAL ORIGIN

^{Medical Service of the Massachusetts General Hospital, Boston}

^{Department of Medicine of the Harvard Medical School, Boston}

The expenses of this investigation were defrayed in part by the Josiah Macy, Jr. Foundation and by a grant from the Committee on Endocrinology of the National Research Council. The work described in this paper was done under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and the Massachusetts General Hospital.

The authors wish to thank the Schering Corporation, Bloomfield, New Jersey, for the generous supplies of methyl testosterone (Oreton-M) and the Ayerst, McKenna and Harrison Company, New York, for the large amounts of chorionic gonadotropin (A.P.L.) used in these studies.

Read by title at the 36th annual meeting of the American Society for Clinical Investigation, May 8, 1944.

Find articles by Reifenstein, E. in: JCI | PubMed | Google Scholar

^{Medical Service of the Massachusetts General Hospital, Boston}

^{Department of Medicine of the Harvard Medical School, Boston}

The expenses of this investigation were defrayed in part by the Josiah Macy, Jr. Foundation and by a grant from the Committee on Endocrinology of the National Research Council. The work described in this paper was done under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and the Massachusetts General Hospital.

The authors wish to thank the Schering Corporation, Bloomfield, New Jersey, for the generous supplies of methyl testosterone (Oreton-M) and the Ayerst, McKenna and Harrison Company, New York, for the large amounts of chorionic gonadotropin (A.P.L.) used in these studies.

Read by title at the 36th annual meeting of the American Society for Clinical Investigation, May 8, 1944.

Find articles by Forbes, A. in: JCI | PubMed | Google Scholar

^{Medical Service of the Massachusetts General Hospital, Boston}

^{Department of Medicine of the Harvard Medical School, Boston}

The expenses of this investigation were defrayed in part by the Josiah Macy, Jr. Foundation and by a grant from the Committee on Endocrinology of the National Research Council. The work described in this paper was done under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and the Massachusetts General Hospital.

The authors wish to thank the Schering Corporation, Bloomfield, New Jersey, for the generous supplies of methyl testosterone (Oreton-M) and the Ayerst, McKenna and Harrison Company, New York, for the large amounts of chorionic gonadotropin (A.P.L.) used in these studies.

Read by title at the 36th annual meeting of the American Society for Clinical Investigation, May 8, 1944.

Find articles by Albright, F. in: JCI | PubMed | Google Scholar

^{Medical Service of the Massachusetts General Hospital, Boston}

^{Department of Medicine of the Harvard Medical School, Boston}

The expenses of this investigation were defrayed in part by the Josiah Macy, Jr. Foundation and by a grant from the Committee on Endocrinology of the National Research Council. The work described in this paper was done under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and the Massachusetts General Hospital.

The authors wish to thank the Schering Corporation, Bloomfield, New Jersey, for the generous supplies of methyl testosterone (Oreton-M) and the Ayerst, McKenna and Harrison Company, New York, for the large amounts of chorionic gonadotropin (A.P.L.) used in these studies.

Read by title at the 36th annual meeting of the American Society for Clinical Investigation, May 8, 1944.

Find articles by Donaldson, E. in: JCI | PubMed | Google Scholar

^{Medical Service of the Massachusetts General Hospital, Boston}

^{Department of Medicine of the Harvard Medical School, Boston}

The expenses of this investigation were defrayed in part by the Josiah Macy, Jr. Foundation and by a grant from the Committee on Endocrinology of the National Research Council. The work described in this paper was done under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and the Massachusetts General Hospital.

The authors wish to thank the Schering Corporation, Bloomfield, New Jersey, for the generous supplies of methyl testosterone (Oreton-M) and the Ayerst, McKenna and Harrison Company, New York, for the large amounts of chorionic gonadotropin (A.P.L.) used in these studies.

Read by title at the 36th annual meeting of the American Society for Clinical Investigation, May 8, 1944.

Find articles by Carroll, E. in: JCI | PubMed | Google Scholar